GSK says Ebola vaccine development progressing at 'unprecedented rate'

LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline said on Saturday work to develop a vaccine to combat Ebola, which has killed thousands in West Africa, was moving at a rapid pace.

via Reuters: Health News Read More Here..